Piramal Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 1,729.31 | 1,273.02 | 1,390.77 |
| Operating Expense | 1,273.22 | 1,028.98 | 1,031.50 |
| Net Profit | 277.27 | 118.80 | 210.06 |
| Net Profit Margin | 16.03 | 9.33 | 15.10 |
| Earning Per Share | 2.09 | 0.90 | 1.59 |
| EBIDTA | 438.55 | 244.26 | 355.25 |
| Effective Tax Rate | 15.25 | 16.73 | 17.15 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 1729.31 |
| Operating Expense | 1273.22 |
| Net Profit | 277.27 |
| Net Profit Margin | 16.03 |
| Earning Per Share | 2.09 |
| EBIDTA | 438.55 |
| Effective Tax Rate | 15.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 4,390.11 | 3,443.22 | 3,340.42 |
| Operating Expenses Annual | 3,772.19 | 3,345.69 | 2,865.14 |
| Operating Profit Annual | 819.98 | 431.64 | 684.99 |
| Interest Annual | 107.10 | 115.87 | 57.29 |
| Depreciation | 205.26 | 192.08 | 165.37 |
| Net Profit Annual | 391.22 | 69.50 | 367.54 |
| Tax Annual | 116.40 | 54.19 | 94.79 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 4,390.11 |
| Operating Expenses Annual | 3,772.19 |
| Operating Profit Annual | 819.98 |
| Interest Annual | 107.10 |
| Depreciation | 205.26 |
| Net Profit Annual | 391.22 |
| Tax Annual | 116.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 54.28 | 127.69 | 146.72 |
| Cash Flow from Operations | 358.29 | 71.52 | 249.19 |
| Cash Flow from Investing | -635.15 | -435.05 | -1,164.62 |
| Cash Flow from Financing | 451.38 | 290.12 | 896.40 |
| Cash Flow at the End | 228.80 | 54.28 | 127.69 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 54.28 |
| Cash Flow from Operations | 358.29 |
| Cash Flow from Investing | -635.15 |
| Cash Flow from Financing | 451.38 |
| Cash Flow at the End | 228.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 18.68 | 12.54 | 20.51 |
| PBIT Margin (%) | 14 | 6.96 | 15.56 |
| PBT Margin (%) | 13.87 | 6.90 | 15.29 |
| Net PROFIT Margin (%) | 8.91 | 2.02 | 11.00 |
| Return On Networth / Equity (%) | 6.53 | 1.34 | 7.97 |
| Return On Networth /Employed (%) | 8.27 | 3.62 | 9.82 |
| Return On Assets (%) | 5.26 | 1.05 | 6.93 |
| Total Debt / Equity (X) | 0.24 | 0.27 | 0.15 |
| Asset Turnover Ratio (%) | 0.59 | 0.52 | 0.63 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 18.68 |
| PBIT Margin (%) | 14 |
| PBT Margin (%) | 13.87 |
| Net PROFIT Margin (%) | 8.91 |
| Return On Networth / Equity (%) | 6.53 |
| Return On Networth /Employed (%) | 8.27 |
| Return On Assets (%) | 5.26 |
| Total Debt / Equity (X) | 0.24 |
| Asset Turnover Ratio (%) | 0.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 2,913 | 2,881.94 | 2,686.67 |
| Total Current Assets Annual | 3,291.55 | 2,348.68 | 2,102.14 |
| Non Current Assets Annual | 6,259.33 | 5,693.72 | 5,268.90 |
| Total Shareholders Funds Annual | 6,712.07 | 5,261.79 | 5,123.12 |
| Total Assets Annual | 9,550.88 | 8,042.40 | 7,371.04 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 2,913 |
| Total Current Assets Annual | 3,291.55 |
| Non Current Assets Annual | 6,259.33 |
| Total Shareholders Funds Annual | 6,712.07 |
| Total Assets Annual | 9,550.88 |
EPS (INR)
Expected
1.16
Reported
1.16
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
